kaz7
Well-Known Member
Ok i forgot that , rushi has done wellfinancial support? Not done bad at all on that either.
Ok i forgot that , rushi has done wellfinancial support? Not done bad at all on that either.
Few words on the longevity of antibodies; this is the study current best knowledge is based on in the UK. That those with antibodies or a previous positive PCR have much lower reinfection rate than not.
The study concludes that after 5 months of follow up on this cohort, "prior SARS-CoV-2 infection protects most individuals against reinfection for at least five months".
Further follow up will provide more data but it is extremely likely, given the prevalence of antibodies after 5 months, that they'll last longer than that. Best knowledge = min 5 months for the vast majority
![]()
Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort study (the SIREN study), England: June to November 2020
Background There is an urgent need to better understand whether individuals who have recovered from COVID-19 are protected from future SARS-CoV-2 infection. Methods A large multi-centre prospective cohort was recruited from publicly funded hospital staff in the UK. Participants attended regular...www.medrxiv.org
Just seen on Euronews...they're not happy over there.A direct text from someone very much in the know on our vaccine supply vs the eu.
It's Ronnie Kray.
I want it to last longer than five months , why wouldnt i ?bloody hell karen won’t like that! Come on Karen it could be longer than 5 months!
I want it to last longer than five months , why wouldnt i ?
Preprint and not peer reviewed so care is needed
Whilst the exact length of immunity conferred by natural infection is still unknown, titres of neutralising antibodies against SARS-CoV-2 spike protein were detectable for at least five months after primary infection.30
On vaccine's it's been good (so far), and they also got (and continue to get) the furlough scheme right, millions still have a job if/when normality comes back, at huge cost to the government.about the only thing they have got right mind you
I’d also add according to Scottish figures so far 45% of over 80s have been done and 96% of total vaccinations so far were with the pfizer which surprised me this afternoon. Don’t know for England.
Is it possible Pfizer is being used on the older and most vulnerable first, maybe most over 70s?
My mum is 73 and had the Oxford jab in Eccles today, she didn’t have to wait for the 15 minutes observation although said some people had to so presumably they had Pfizer. Could be basing it on age in some locations?I’d also add according to Scottish figures so far 45% of over 80s have been done and 96% of total vaccinations so far were with the pfizer which surprised me this afternoon. Don’t know for England.
Is it possible Pfizer is being used on the older and most vulnerable first, maybe most over 70s?
I have a quick read and it doesnt say it is extremely likely to last longer , trials report findings and not surmising past thatOnly pulling your leg - good quote but add at the end “and extremely likely to last longer”
How come none of the other 27 countries took the chance then?And yet again, we have done nothing that EU membership precluded us from.
As confirmed by the head of the MHRA.
Just a follow up to this story...
It surely wouldn't make sense to approve it at all if efficacy is only 8%? The Sanofi/GSK vaccine has had to start the whole trial process again as it was shown to be effective for younger age groups but far less for older groups. You can't imagine that one was only 8% either.I will speculate.
The UK information for healthcare professionals quotes:
The number of COVID-19 cases (2) in 660 participants ≥65 years old were too few to draw conclusions on efficacy
and
However, in this subpopulation, immunogenicity data are available, see below.
In other words, the trial proved efficacy in the overall population, but the approval depends on showing equivalent immune response (antibody generation) in older subjects rather than efficacy directly.
My guess is that the very small numbers in the older age group means there is a very large confidence interval on efficacy in that age group, and the lower limit of the confidence interval is 8%. If so, it absolutely does not mean efficacy is 8%, and the MHRA view is that the demonstration of equivalent immune response is sufficient to justify temporary authorisation.
As I said, just speculation.
God you are relentlessWith the bans on foreign travel, our beaches are going to be busier this year than last year. Looking forward to bbc news interviewing sunbathers expressing their “surprise” that so many people are there once again. Yawn.
Mines 79 and she had the Oxford (only 1 so far), my dad 82 had Pfizer, and he's had both doses.My mum is 73 and had the Oxford jab in Eccles today, she didn’t have to wait for the 15 minutes observation although said some people had to so presumably they had Pfizer. Could be basing it on age in some locations?
Sounds like the Der Spiegel hatchet job on City. Shithouses won’t fess up who their source is. Oxford/AZ should take it to CAS